Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003).
Int J Clin Oncol
; 22(6): 1052-1059, 2017 Dec.
Article
in En
| MEDLINE
| ID: mdl-28667408
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oxonic Acid
/
Stomach Neoplasms
/
Tegafur
/
Antimetabolites, Antineoplastic
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Int J Clin Oncol
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
Japón
Country of publication:
Japón